Tempus Announces the National Launch of FDA-Approved xT CDx Test
Go back to Tempus Announces the National Launch of FDA-Approved xT CDx Test| StemCells, Inc. (NASDAQ: TEM) | Delayed: 68.66 +2.01 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.65 | 52 Week High | $0.45 | |||
| Open | $65.60 | 52 Week Low | $0.37 | |||
| Day High | $68.90 | P/E | N/A | |||
| Day Low | $65.25 | EPS | $-0.31 | |||
| Volume | 3,146,997 | |||||
